In HCC, ARID2 mutations have been associated with HCV infection and with ß-catenin activating mutations in CTNNB1. This can be correlated with the fact that CTNNB1-mutated HCC are mostly associated with non-viral and HCV etiologies [47,76]. This evidence concerns the gene ARID2 and hepatocellular carcinoma.